APR1 6 2004

Summary of Safety and Effectiveness

i. Submission Applicant & Correspondent
Name: Instrumed International, INC.
Address: 626 Cooper Court

Schaumburg, IL 60173
|

Phone: 847-908-0292
Fax: 847-908-0293
Mail: jwalsh@instrumedinc. biz
Contact person: Jim Walsh

2. Device name & Classification panel
Trade name Laparoscope & Monopolar

laparoscopic instruments

Common name: Laparoscope & Accessories
Classification: 876.1500

3. Substantial Equivalence
Substantial Equivalence is claimed to the following devices
Gimmi Laparoscope
Manufactured by
Gimmi GmbH
Registered in the FDA Database under the following number; KO12660

Se
4, Description of device
Instrumed Laparoscopes provide illumination and visualization in diagnostic
procedures and in conjunction with laparoscopic instruments (accessories) operative
laparoscopic procedures

5. Intended Use & Indications
Instrumed Laparoscopes and Accessories are intended to be used by qualified
physicians to provide access, illumination and visualization of interna{ structures
and for manipulating soft tissue (grasping, cutting, coagulating, dissecting, and
suturing) in a wide variety of diagnostic and therapeutic laparoscopic/ urologic clased
and minimally invasive procedures.
|

eee

6. Technical Comparison

The Instrumed product is similiar to the Gimmi product in terms of design and

technical characteristics. The Laparoscope and the respective laparoscopic

instruments are identical to the Gimmi products.

The Instrumed product is also similiar to the Gimmi products in terms of the used

material.

In terms of performance data, the presented data that was conducted on the

Instrumed instruments shows in its results that the Laparoscope and the laparoscopic

instruments are absolutely safe and effective for its intended use and do not raise any

questions regarding safety and effectiveness.

j DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service
Ga
e Food and Drug Administration
9200 Corporate Boulevard
APR 1 6 04 Rockville MD 20850
Instrumed International, Inc.
c/o Mr. Stefan Preiss
TUV America, Inc. .
1775 Old Highway 8
New Brighton, Minnesota 55112
Re: K040855
Trade/Device Name: Instrumed Laparoscopes and Accessories
Regulation Number: 21 CFR 878.4400, 876.1500
Regulation Name: Electrosurgical cutting and coagulation device and accessories;
Endoscope and accessories
Regulatory Class: If
Product Code: GEI, GCI
Dated: March 25, 2004
Received: April 2, 2004
Dear Mr. Preiss:
We have reviewed your Section 510(k) premarket notification of intent to market the device
referenced above and have determined the device is substantially equivalent (for the indications
for use stated in the enclosure) to legally marketed predicate devices marketed in interstate
commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to
devices that have been reclassified in accordance with the provisions of the Federal Food. Drug,
and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA).
You may, therefore, market the device, subject to the general controls provisions of the Act. The
general controls provisions of the Act include requirements for annual registration, listing of
devices, good manufacturing practice, labeling, and prohibitions against misbranding and
: adulteration.
If your device is classified (sce above) into either class Il (Special Controls) or class IIT (PMA), it
may be subject to such additional controls. Existing major regulations affecting your device can
be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may
publish further announcements concerning your device in the Federal Register.
Please be advised that FDA’s issuance of a substantial equivalence determination does not mean
that FDA has made a determination that your device complies with other requirements of the Act
or any Federal statutes and regulations administered by other Federal agencies. You must
comply with all the Act’s requirements, including, but not limited to: registration and listing (21
CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set
forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic
product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Page 2 - Mr. Stefan Preiss
This letter will allow you to begin marketing your device as described in your Section 510¢k)
premarket notification. The FDA finding of substantial equivalence of your device to a legally
marketed predicate device results in a classification for your device and thus, permits your device
to proceed to the market. .
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please
contact the Office of Compliance at (301) 594-4659. Also, please note the regulation entitled,
"Misbranding by reference to premarket notification” (21CFR Part 807.97). You may obtain
other general information on your responsibilities under the Act from the Division of Small
Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or
(301) 443-6597 or at its Internet address http://www.fda.gov/edrh/dsma/dsmamain.html

Sincerely yours,

alll, dk ail AN re

Celia M. Witten, Ph.D., M.D.

Director

Division of General, Restorative

‘ and Neurological Devices

Office of Device Evaluation

Center for Devices and Radiological Health
Enclosure .

Indications for Use
540(k) Number (if known): _
Device Name: Instrumed Laparoscopes and /\ccessories :
indications for Use:
instrumed Laparoscopes and Accessories ar2 intended to be used by qualified
physicians to provide access, illumination an 4 visualization of internal structures
and for manipulating soft tissue (grasping, cutting, coagulating, dissecting, and
suturing) in a wide variety of diagnostic and herapeutic laparoscopic/urologic closed
and minimally invasive procedures,
Af gs if
tbo
ivision Sign-Off)
Division of General, Restorative,
and Neurological Devices
2
c408SS
510(k) Number... K O19 >
a
Prescription Use an ANE OR Over-The-Counter Use __
(Part 21 CFR 801 Subpart D) (21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW TH S LINE-CONTINUE ON ANOTHER PAGE
OF NEEDED) —
Concurrence of CDRH, Off ce of Device Evaluation (ODE)
Page__ of __._

